Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration].

Vestnik oftalmologii - 1 Jan 2000

Budzinskaia M V, Pogoda T V, Generozov E V, Chikun E A, Gurova I V, Shchegoleva I V, Sizova M V

Abstract excerpt

A study on the role of CFH, HTRA and IL-8 gene polymorphism in age-related macular degeneration (AMD) development has been conducted. At the first stage of the study genetic testing was done in 69 patients with exudative AMD and 370 random Moscow citizens without the disease. The goal of the second stage was to determine the influence of gene polymorphism on patient's response to endovitreal ranibizumab...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescein Angiography

Share to Fundus Oculi

Share to High-Temperature Requirement A Serine Peptidase 1

Share to Interleukin-8

Share to Intravitreal Injections

Share to Visual Acuity

Source

Identifiers

PMID: 24261289

Genes

CFH
HTRA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration].PMID 24261289Read ↗

[Molecular genetic basis of age-related macular degeneration].Semantic proximity Read ↗

[Genetic aspects of age-related macular degeneration].Semantic proximity Read ↗

Towards the application of precision medicine in Age-Related Macular Degeneration.Semantic proximity Read ↗

[Genetic factors associated with age-related macular degeneration].Semantic proximity Read ↗

[Update on the genetics of age-related macular degeneration].Semantic proximity Read ↗

[The pharmacogenomics of CFH Y402H and wet age-related macular degeneration].Semantic proximity Read ↗

[Advances in the molecular genetic epidemiology research of age-related macular degeneration].Semantic proximity Read ↗

Investigation of genetic base in the treatment of age-related macular degeneration.Semantic proximity Read ↗

[Age-related macular degeneration--a complex genetic disease].Semantic proximity Read ↗

[Identification of susceptibility genes for age-related macular degeneration--a success story of molecular genetics].Semantic proximity Read ↗

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Semantic proximity Read ↗

The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.